🇺🇸 FDA
Patent

US 11939604

Modified cascade ribonucleoproteins and uses thereof

granted A61KA61K38/00A61K48/005

Quick answer

US patent 11939604 (Modified cascade ribonucleoproteins and uses thereof) held by Caribou Biosciences, Inc. expires Mon Mar 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Caribou Biosciences, Inc.
Grant date
Tue Mar 26 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K38/00, A61K48/005, A61P, A61P31/12